{"id":"W2775399881","doi":"10.1093/ibd/17.supplement1.s46","title":"Dose increase patterns in patients treated with tumor necrosis factor antagonists (anti-TNFs) for Crohn's disease (CD) in Canada.","year":2011,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Crohn's disease; Medicine; Tumor necrosis factor alpha; Disease; Internal medicine; Tumor necrosis factor α; Gastroenterology; Necrosis; Infliximab; Crohn disease; Tumor necrosis factors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008964561,0.0003819972,0.0006428693,0.002195496,0.001285044,0.001339252,0.001308853,0.0006180698,0.002046193],"category_scores_gemma":[0.005242304,0.0003379051,0.0009581458,0.007001259,0.000472746,0.0004007098,0.0006391707,0.0008566076,0.0001928112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03221778,"about_ca_system_score_gemma":0.02075776,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.962498,"about_ca_topic_score_gemma":0.971502,"domain_scores_codex":[0.9969947,0.0002651544,0.0003312064,0.0005276818,0.001304417,0.0005768264],"domain_scores_gemma":[0.9948855,0.0004635855,0.002403914,0.000164007,0.001449255,0.0006336852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004215948,0.00005464885,0.9903873,0.00008638928,0.0001339615,0.0001106949,0.0002395696,0.0003292449,0.0001936038,0.000134546,0.00123142,0.00667711],"study_design_scores_gemma":[0.00005061156,0.00008573764,0.9960151,0.0000300877,0.00007729443,0.0002264643,0.0003773811,0.001130273,0.0001356964,0.00003881419,0.001811008,0.00002146704],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806659,0.002027691,0.0003483077,0.0005282448,0.00001539243,0.0001881628,0.01393099,0.00004396898,0.002251393],"genre_scores_gemma":[0.9937453,0.0005763883,0.0007346036,0.000233337,0.000008722673,0.00004417567,0.004117612,0.00001308477,0.0005265295],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03750199,"threshold_uncertainty_score":0.2337574,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007546379959035167,"score_gpt":0.2014263614579151,"score_spread":0.1938799814988799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}